Alkermes plc Total Non Current Liabilities 2011-2025 | ALKS

Annual Total Non Current Liabilities Alkermes plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	329 M	314 M	303 M	305 M	305 M	392 M	432 M	492 M	12.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
492 M	12.4 M	321 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.75	-0.84 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	5.95 M	$ 3.02	-0.66 %	$ 233 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 0.22	23.66 %	$ 479 M	Israel
Aptorum Group Limited APM	2.21 M	$ 1.16	-1.28 %	$ 6.33 M	China
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Ascendis Pharma A/S ASND	101 M	$ 209.08	-1.75 %	$ 5 B	Danmark
Celldex Therapeutics CLDX	17.3 M	$ 26.17	-2.46 %	$ 1.69 M	USA
Aptevo Therapeutics APVO	5 M	$ 0.56	-40.06 %	$ 155 K	USA
Cellectar Biosciences CLRB	422 K	$ 2.6	-5.8 %	$ 31.8 M	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.15	1.78 %	$ 7.58 B	Australia
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
BioVie BIVI	62.5 K	$ 1.18	-7.48 %	$ 1.74 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
BioNTech SE BNTX	341 M	$ 94.08	-1.0 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	69.4 M	$ 26.92	0.41 %	$ 1.3 B	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Anika Therapeutics ANIK	26.1 M	$ 9.49	0.13 %	$ 139 M	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Dynavax Technologies Corporation DVAX	218 M	$ 15.4	0.1 %	$ 2 B	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Axon Enterprise AXON	107 M	$ 586.59	-0.77 %	$ 44.4 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Eton Pharmaceuticals ETON	4.56 M	$ 16.76	-1.38 %	$ 430 M	USA
Evogene Ltd. EVGN	5.36 M	$ 1.03	-1.9 %	$ 27.9 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.47	-2.37 %	$ 15.5 M	USA
AstraZeneca PLC AZN	30.8 B	$ 92.63	0.19 %	$ 96.9 B	Britain
Exelixis EXEL	63.6 M	$ 46.5	-0.03 %	$ 13.5 B	USA
Foghorn Therapeutics FHTX	97.7 M	$ 5.38	-0.37 %	$ 295 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Catalyst Biosciences CBIO	981 K	$ 12.48	0.89 %	$ 822 M	USA